Randomized Trial of Ezetimibe Versus nutraCeuticals in Statin-intoLerant patIents Treated With PercutaneouS Coronary Intervention
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Ezetimibe (Primary) ; Berberine/monascus/policosanol
- Indications Angina pectoris
- Focus Adverse reactions; Therapeutic Use
- Acronyms ECLIPSE
- 06 Mar 2013 Planned End Date changed from 1 Dec 2013 to 1 Dec 2016 as reported by ClinicalTrials.gov
- 07 Nov 2012 Results presented at the 85th Annual Scientific Sessions of the American Heart Association.
- 19 Jul 2012 Additional trial investigator identified as reported by ClinicalTrials.gov.